DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Tannir NM, Hammers H, Amin A. et al.
Nivolumab + ipilimumab (N+I) v sunitinib (S) for treatment-naïve advanced renal cell carcinoma (aRCC): Safety results from CheckMate 214.
J Clin Oncol 2018;
6: 686-686
We do not assume any responsibility for the contents of the web pages of other providers.